Earth Science Tech Inc. (OTC: ETST) recently reported financial results for the fiscal year ended March 31, 2026, showcasing growth across key metrics as the company continues to execute its diversified holdings strategy in healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST’s efforts to fully integrate the patient experience across telemedicine to pharmacy to fulfillment. The company’s core value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. This end-to-end platform connects telemedicine consultations with compounding pharmacy operations and direct-to-patient fulfillment, creating a unified healthcare delivery system.
The company operates as a diversified holding company focused on the health and wellness sector, with a principal strategy of building a vertically integrated healthcare platform. Its healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. By combining these elements, ETST aims to streamline the patient journey and improve outcomes.
For more details, the full article is available at https://nnw.fm/u6mhk. Additional information about Earth Science Tech can be found at www.EarthScienceTech.com. The latest news and updates relating to ETST are available in the company’s newsroom at https://nnw.fm/ETST.
Earth Science Tech’s results reflect the growing importance of integrated healthcare platforms that bridge telemedicine, pharmacy, and fulfillment. As patients increasingly seek convenient, end-to-end healthcare solutions, companies like ETST that can offer seamless digital and physical care may be well-positioned for future growth. The company’s diversified holdings model also provides stability through multiple revenue streams across healthcare, real estate, and consumer products.
With a 27% increase in total assets and strong profitability metrics, ETST demonstrates the potential of its vertically integrated approach. The company’s focus on compounding pharmacy and direct-to-patient fulfillment addresses a niche but growing segment of personalized medicine, where customized medications are prepared for individual patient needs. This, combined with telemedicine capabilities, allows for a more tailored and accessible healthcare experience.
Investors and industry observers will watch how ETST continues to expand its platform and whether it can sustain its growth trajectory. The company’s ability to integrate diverse operations under one holding structure may serve as a model for other firms seeking to capitalize on the convergence of healthcare and technology.
